Perinatal Domoic Acid as a Neuroteratogen

Tracy A Doucette1, R Andrew Tasker2

  • 1Department of Psychology, University of Prince Edward Island, 550 University Avenue, Charlottetown, PE, C1A4P3, Canada.

Insights

Exposure to domoic acid (DOM) during early development causes lasting neurological damage in rats. This research highlights DOM

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Toxicology

Background:

  • The perinatal period is critical for brain development and highly susceptible to injury.
  • Neurological diseases can originate from birth trauma, often with delayed diagnosis.
  • Domoic acid (DOM) is a known neurotoxin found in seafood, posing risks to wildlife and humans.

Purpose of the Study:

  • To investigate the neurodevelopmental toxicity of domoic acid (DOM) in a rat model.
  • To characterize the long-term behavioral and neuropathological effects of perinatal DOM exposure.
  • To evaluate the adequacy of current regulatory limits for DOM based on adult toxicity data.

Main Methods:

  • Exposure of newborn rats to low doses of domoic acid (DOM).
  • Longitudinal assessment of behavioral changes.
  • Detailed neuropathological examination of the developing brain.

Main Results:

  • Perinatal exposure to low-dose DOM causes significant neurotoxicity in developing rat brains.
  • DOM exposure leads to detectable long-term behavioral deficits.
  • Neuropathological changes indicate lasting damage to brain structures.

Conclusions:

  • Domoic acid (DOM) is a potent neuroteratogen, posing a greater risk to the developing brain than previously recognized.
  • Current regulatory standards for DOM may be insufficient to protect against developmental neurotoxicity.
  • This study provides a novel model for investigating the progression of neurodevelopmental disorders.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
168